China Nod At Regulatory Improvements Will Widen Doors For US Medtech
This article was originally published in Clinica
Chinese officials have agreed to address regulatory challenges to improve access for US firms to China's medical device market following talks with American counterparts and medical device industry representatives. The targeted reforms include lowering clinical trial barriers for some class II and class III devices.
You may also be interested in...
Medical device companies operating in China are still looking for clearer guidance that will help them make the most of the wide-ranging regulatory reforms introduced in the country since 2014.
Erectile problems prevent a quarter of Brits from being intimate with a partner. Viatris' Upjohn - which markets Viagra Connect in the UK - is working with the Men’s Health Forum, sexual health charity Brook and dating expert Sarah Louise Ryan raise awareness of the problem and get men talking about the issue with their partners and with healthcare professionals.
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.